Fulvestrant 500mg in Patients With Advanced Breast Cancer
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT02909361
Ages eligible for Study
18 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Chinese women with estrogen receptor positive, locally advanced or metastatic breast cancer who has already received Fulvestant 500mg treatment as determined by treating physician. Ovarian suppression in premenopausal women is permitted, including ovarian ablation and LHRHa.
Histologically confirmed positive oestrogen receptor status (ER positive) of primary breast cancer or metastatic tumour tissue, according to the local laboratory parameters.
Prior endocrine therapy for advanced disease was not permitted.
The prescription of the Fulvestant is clearly separated from the decision to include the subject in the NIS, and is part of normal medical practice. The recruitment of the patient to the study should be within 1 month of the first Fulvestant injection.
Provision of subject informed consent.
If participating in any controlled clinical trial, the subject cannot take part in this study.
HER2 overexpression or gene amplification, ie, immunohistochemistry (IHC) 3+ or fluorescence in situ hybridisation (FISH)+, where appropriate.
Pervious regimen of endocrine therapy for advanced disease.
More than one regimen of chemotherapy for advanced disease.
Pregnancy and lactation.
Severe hepatic impairment.
All locations for NCT02909361
Fudan University Cancer Hospital
Shanghai, China, 200032
Put me in touch!
View full eligibility
Tris trial is registered with FDA with number: NCT02909361. The sponsor of the trial is Fudan University and it is looking for 500 volunteers for the current phase.
Official trial title: A Multicenter, Prospective, Real-world Study to Evaluate the Safety Profile and Effectiveness in Chinese Patients Who Received Fulvestrant 500mg as First-line Endocrine Treatment for Advanced Breast Cancer
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.